How Spinopelvic Movements Affect Hip Function After Total Hip Arthroplasty
NCT ID: NCT06711042
Last Updated: 2025-02-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
60 participants
OBSERVATIONAL
2024-12-01
2025-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Reliability and Validity of the Six-Spot Step Test After Total Hip Arthroplasty
NCT06704217
Patient Scores and Functional Tests After Hip Surgery
NCT07048041
The Postural Control in Patients After Total Hip Replacement
NCT03218267
Investigation of the Effects of Balance Training on Balance and Functional Status Patients With Total Hip Arthroplasty
NCT04433962
Investigating Postural Parameters in Different Hip Pathologies
NCT06851793
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control Group (Implant Placement Within Functional Safe Zone - FSZ)
This group will consist of patients who have previously undergone total hip arthroplasty (TKA) with implant placement within the functional safe zone (FSZ).
functional tests and radiographic analysis
In this observational study, no active interventions or treatments will be administered to the participants. Both groups (Control Group and Experimental Group) will undergo clinical evaluations, including functional tests (WOMAC, Harris Hip Score, Oxford Hip Score, SF-12, TUG) and radiographic analysis (angular measurements). The participants' outcomes will be compared based on their implant placement (within or outside the Functional Safe Zone).
Experimental Group (Implant Placement Outside Functional Safe Zone - FSZ)
This group will consist of patients who have previously undergone total hip arthroplasty (TKA) but have implant placement outside the functional safe zone (FSZ).
functional tests and radiographic analysis
In this observational study, no active interventions or treatments will be administered to the participants. Both groups (Control Group and Experimental Group) will undergo clinical evaluations, including functional tests (WOMAC, Harris Hip Score, Oxford Hip Score, SF-12, TUG) and radiographic analysis (angular measurements). The participants' outcomes will be compared based on their implant placement (within or outside the Functional Safe Zone).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
functional tests and radiographic analysis
In this observational study, no active interventions or treatments will be administered to the participants. Both groups (Control Group and Experimental Group) will undergo clinical evaluations, including functional tests (WOMAC, Harris Hip Score, Oxford Hip Score, SF-12, TUG) and radiographic analysis (angular measurements). The participants' outcomes will be compared based on their implant placement (within or outside the Functional Safe Zone).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* At least 12 months post-surgery.
Exclusion Criteria
* Patients with hip infection or advanced osteoarthritis in the contralateral hip.
* Patients with leg length discrepancy.
* Patients with neurological, orthopedic, or systemic diseases affecting gait or balance.
* Patients with a body mass index (BMI) greater than 40 kg/m².
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ordu University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Elif AYGUN POLAT
PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yusuf POLAT, Assoc.Prof.
Role: STUDY_DIRECTOR
Ordu University
Elif AYGUN POLAT, PhD
Role: PRINCIPAL_INVESTIGATOR
Ordu University
Murat ALPARSLAN, MD
Role: PRINCIPAL_INVESTIGATOR
Ordu University
Tolga KECECİ, Assoc.Prof.
Role: PRINCIPAL_INVESTIGATOR
Ordu University
Alper ÇIRAKLI, Prof.
Role: STUDY_CHAIR
Ordu University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ordu University
Ordu, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ODU-SBFTR-AYGUNPOLAT-004
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.